These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 19432520)

  • 1. Interplay of efflux, impermeability, and AmpC activity contributes to cefuroxime resistance in clinical, non-ESBL-producing isolates of Escherichia coli.
    Källman O; Giske CG; Samuelsen Ø; Wretlind B; Kalin M; Olsson-Liljequist B
    Microb Drug Resist; 2009 Jun; 15(2):91-5. PubMed ID: 19432520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emergence of imipenem resistance in clinical Escherichia coli during therapy.
    Oteo J; Delgado-Iribarren A; Vega D; Bautista V; Rodríguez MC; Velasco M; Saavedra JM; Pérez-Vázquez M; García-Cobos S; Martínez-Martínez L; Campos J
    Int J Antimicrob Agents; 2008 Dec; 32(6):534-7. PubMed ID: 18775649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of plasmid-mediated AmpC in Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis.
    Tan TY; Ng SY; Teo L; Koh Y; Teok CH
    J Clin Pathol; 2008 May; 61(5):642-4. PubMed ID: 18057079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression levels of chromosomal AmpC β-lactamase in clinical Escherichia coli isolates and their effect on susceptibility to extended-spectrum cephalosporins.
    Paltansing S; Kraakman M; van Boxtel R; Kors I; Wessels E; Goessens W; Tommassen J; Bernards A
    Microb Drug Resist; 2015 Feb; 21(1):7-16. PubMed ID: 25188329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of extended-spectrum beta-lactamases by using boronic acid as an AmpC beta-lactamase inhibitor in clinical isolates of Klebsiella spp. and Escherichia coli.
    Song W; Bae IK; Lee YN; Lee CH; Lee SH; Jeong SH
    J Clin Microbiol; 2007 Apr; 45(4):1180-4. PubMed ID: 17301276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence of ESBL-producing E. coli and Klebsiella strains in the Copenhagen area of Denmark.
    Kjerulf A; Hansen DS; Sandvang D; Hansen F; Frimodt-Møller N
    APMIS; 2008 Feb; 116(2):118-24. PubMed ID: 18321362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to extended-spectrum beta-lactams by the emergence of SHV-12 and the loss of OmpK35 in Klebsiella pneumoniae and Escherichia coli in Malaysia.
    Palasubramaniam S; Muniandy S; Navaratnam P
    J Microbiol Immunol Infect; 2009 Apr; 42(2):129-33. PubMed ID: 19597644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cefuroxime non-susceptibility in multidrug-resistant Klebsiella pneumoniae overexpressing ramA and acrA and expressing ompK35 at reduced levels.
    Källman O; Motakefi A; Wretlind B; Kalin M; Olsson-Liljequist B; Giske CG
    J Antimicrob Chemother; 2008 Nov; 62(5):986-90. PubMed ID: 18647746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular analysis of porin gene transcription in heterogenotypic multidrug-resistant Escherichia coli isolates from scouring calves.
    Vinson HM; Gautam A; Olet S; Gibbs PS; Barigye R
    J Antimicrob Chemother; 2010 Sep; 65(9):1926-35. PubMed ID: 20639525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase.
    Weston GS; Blázquez J; Baquero F; Shoichet BK
    J Med Chem; 1998 Nov; 41(23):4577-86. PubMed ID: 9804697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The AmpC phenotype in Norwegian clinical isolates of Escherichia coli is associated with an acquired ISEcp1-like ampC element or hyperproduction of the endogenous AmpC.
    Haldorsen B; Aasnaes B; Dahl KH; Hanssen AM; Simonsen GS; Walsh TR; Sundsfjord A; Lundblad EW
    J Antimicrob Chemother; 2008 Oct; 62(4):694-702. PubMed ID: 18583329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Investigation of plasmid-mediated AmpC beta-lactamase types in Klebsiella spp. and Escherichia coli isolates resistant or intermediate to cefoxitin].
    Demirbakan H; Midilli K; Oğünç D; Ozen N; Ongüt G; Dağlar D; Mutlu D; Ozhak B; Colak D
    Mikrobiyol Bul; 2008 Oct; 42(4):545-51. PubMed ID: 19149075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of high-level cephalosporinase due to mutation in the AmpC attenuator of a clinical Escherichia coli strain].
    Guan XZ; Liu YN; Luo YP; She DY; Lu SJ; Zhou G; Chen LA
    Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(9):600-4. PubMed ID: 16681904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of beta-lactams resistance among Escherichia coli clinical isolates from a hospital in Algiers.
    Messai Y; Benhassine T; Naim M; Paul G; Bakour R
    Rev Esp Quimioter; 2006 Jun; 19(2):144-51. PubMed ID: 16964332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disc methods for detecting AmpC {beta}-lactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae.
    Brenwald NP; Jevons G; Andrews J; Ang L; Fraise AP
    J Antimicrob Chemother; 2005 Sep; 56(3):600-1. PubMed ID: 16087656
    [No Abstract]   [Full Text] [Related]  

  • 16. Expression of the efflux pump genes cmeB, cmeF and the porin gene porA in multiple-antibiotic-resistant Campylobacter jejuni.
    Pumbwe L; Randall LP; Woodward MJ; Piddock LJ
    J Antimicrob Chemother; 2004 Aug; 54(2):341-7. PubMed ID: 15201231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the effectiveness of tazobactam against ceftazidime resistant Escherichia coli: insights from the comparison between susceptibility testing and beta-lactamase inhibition.
    Bethel CR; Hujer AM; Helfand MS; Bonomo RA
    FEMS Microbiol Lett; 2004 May; 234(1):99-103. PubMed ID: 15109726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ampC gene expression in promoter mutants of cefoxitin-resistant Escherichia coli clinical isolates.
    Tracz DM; Boyd DA; Hizon R; Bryce E; McGeer A; Ofner-Agostini M; Simor AE; Paton S; Mulvey MR;
    FEMS Microbiol Lett; 2007 May; 270(2):265-71. PubMed ID: 17326753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence of plasmid-mediated quinolone resistance determinants among clinical isolates of ESBL or AmpC-producing Escherichia coli from Chinese pediatric patients.
    Han C; Yang Y; Wang M; Wang A; Lu Q; Xu X; Wang C; Liu L; Deng Q; Shen X
    Microbiol Immunol; 2010 Mar; 54(3):123-8. PubMed ID: 20236421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic utility of boronic acid inhibition with different cephalosporins against Escherichia coli producing AmpC β-lactamases.
    Upadhyay S; Sen MR; Bhattacharjee A
    J Med Microbiol; 2011 May; 60(Pt 5):691-3. PubMed ID: 21292860
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.